Skip to main content
OpenTrials

Clinical trial condition

Minimal Change Disease (MCD)

Explore clinical trials studying Minimal Change Disease (MCD). Study availability and eligibility vary by location and protocol.

5 public trials 4 recruiting studies
Refine in advanced search Browse all conditions

Minimal Change Disease (MCD) trial results

Recruiting

A Trial to Assess the Efficacy and Safety of Obinutuzumab in Treating Adults With Minimal Change Disease (MCD)

NCT07710157

Conditions
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Kidney Diseases, +6 more
Locations
  • Division of Nephrology, Department of Internal Medicine, Medical University of Graz Graz, Austria
  • Department of Internal Medicine IV, Nephrology and Hypertension Innsbruck, Austria
  • 6. Medizinische Abteilung mit Nephrologie & Dialyse, Klinik Ottakring Vienna, Austria
  • Laboratory of Immunology, Nice University Hospital (CHU de Nice), Côte d'Azur University Nice, France
View Trial Details
Recruiting

Nephrotic Syndrome Study Network

NCT01209000

Conditions
Autoimmune Diseases, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +15 more
Locations
  • University of Southern California-Children's Hospital Los Angeles, California, United States
  • Stanford University School of Medicine Palo Alto, California, United States
  • University of California San Francisco Benioff Children's Hospitals San Francisco, California, United States
  • Lundquist Biomedical Research Institute at Harbor UCLA Medical Center Torrance, California, United States
View all 44 locations
View Trial Details

Related conditions